Trial Search Results
Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
To determine the ability of magnetic resonance lymphangiography using conventional gadolinium injected directly into the tumor site and PET scan in detecting microscopic nodal metastasis in patients with newly diagnosed H&N cancers
Stanford is currently not accepting patients for this trial.
Collaborator: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
- Procedure: IMR LAG
Inclusion Criteria:Patients with newly diagnosed squamous cell carcinomas of the H&N with
primary tumor sites that are accessible to direct contrast injections
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study